Herb-induced autoimmune-like hepatitis in C57BL/6J mice

Liver International

Volumn 34, Issue 4, 2014, Pages 583-593

  Wang, Jir You ^a,b   Lee, Chang Yin ^c,d   Pan, Po Jung ^a   Chang, Wen Chi ^a   Chiu, Jen Hwey ^a,b   Chen, Wei Shone ^b   Shyr, Yi Ming ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

^d E DA HOSPITAL   (Taiwan)

Author keywords

Autoantibody; Autoimmune hepatitis (AIH); Bupleurum chinense DC (Bc); Herbs; Scutellaria baicalensis Georgi (Sb)

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BUPLEURUM CHINENSE EXTRACT; BUPLEURUM ROOT EXTRACT; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CREATININE; CYTOCHROME P450 1A2; CYTOCHROME P450 3A4; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; SCUTELLARIA BAICALENSIS EXTRACT; TRANSCRIPTION FACTOR PAX5; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BUPLEURUM CHINENSE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG INDUCED DISEASE; GENE EXPRESSION PROFILING; IMMUNOMODULATION; MALE; MICROENVIRONMENT; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SCUTELLARIA BAICALENSIS;

AUTOANTIBODY; AUTOIMMUNE HEPATITIS (AIH); BUPLEURUM CHINENSE DC (BC); HERBS; SCUTELLARIA BAICALENSIS GEORGI (SB);

ALANINE TRANSAMINASE; ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES, ANTINUCLEAR; ASPARTATE AMINOTRANSFERASES; BUPLEURUM; CREATININE; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; HEPATITIS, AUTOIMMUNE; IMMUNOGLOBULIN G; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED C57BL; PLANT EXTRACTS; SCUTELLARIA BAICALENSIS;

EID: 84895787603     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12266     Document Type: Article

References (41)

1. Vierling JM. Diagnosis and treatment of autoimmune hepatitis. Curr Gastroenterol Rep 2012; 14: 25-36.
2. Mileti E, Rosenthal P, Peters MG. Validation and modification of simplified diagnostic criteria for autoimmune hepatitis in children. Clin Gastroenterol Hepatol 2012; 10: 417-21 e2.
3. Ferrari R, Pappas G, Agostinelli D, et al. Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type. QJM 2004; 97: 407-12.
4. Berg PA, Klein R. [Autoimmune hepatitis and overlap syndrome: diagnosis]. Praxis (Bern 1994) 2002; 91: 1339-46.
5. Feld JJ, Heathcote EJ. Epidemiology of autoimmune liver disease. J Gastroenterol Hepatol 2003; 18: 1118-28.
6. Tanaka A, Harada K, Ebinuma H, et al. Primary biliary cirrhosis - Autoimmune hepatitis overlap syndrome: A rationale for corticosteroids use based on a nation-wide retrospective study in Japan. Hepatol Res 2011; 41: 877-86.
7. Seldin MF, Amos CI, Ward R, Gregersen PK. The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum 1999; 42: 1071-9.
8. Gregory WL, Daly AK, Dunn AN, et al. Analysis of HLA-class-II-encoded antigen-processing genes TAP1 and TAP2 in primary biliary cirrhosis. Q J Med 1994; 87: 237-44.
9. Graham AM, Dollinger MM, Howie SE, Harrison DJ. Identification of novel alleles at a polymorphic microsatellite repeat region in the human NRAMP1 gene promoter: analysis of allele frequencies in primary biliary cirrhosis. J Med Genet 2000; 37: 150-2.
10. Zappala F, Grove J, Watt FE, et al. No evidence for involvement of the interleukin-10 -592 promoter polymorphism in genetic susceptibility to primary biliary cirrhosis. J Hepatol 1998; 28: 820-3.
11. Longhi MS, Ma Y, Mieli-Vergani G, Vergani D. Aetiopathogenesis of autoimmune hepatitis. J Autoimmun 2010; 34: 7-14.
12. Ferri S, Longhi MS, De Molo C, et al. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology 2010; 52: 999-1007.
13. Christen U. The role of autoantibodies in autoimmune hepatitis type 2. Immunotherapy 2013; 5: 247-56.
14. Larrey D, Pageaux GP. Genetic predisposition to drug-induced hepatotoxicity. J Hepatol 1997; 26(Suppl 2): 12-21.
15. Uetrecht JP. Current trends in drug-induced autoimmunity. Toxicology 1997; 119: 37-43.
16. Fogden E, Neuberger J. Alternative medicines and the liver. Liver Int 2003; 23: 213-20.
17. Teschke R, Wolff A, Frenzel C, Schulze J, Eickhoff A. Herbal hepatotoxicity: a tabular compilation of reported cases. Liver Int 2012; 32: 1543-56.
18. Chitturi S, Farrell GC. Herbal hepatotoxicity: an expanding but poorly defined problem. J Gastroenterol Hepatol 2000; 15: 1093-9.
19. Ikegami F, Fujii Y, Satoh T. Toxicological considerations of Kampo medicines in clinical use. Toxicology 2004; 198: 221-8.
20. Lee WM. Drug-induced hepatotoxicity. N Engl J Med 2003; 349: 474-85.
21. Larrey D. Hepatotoxicity of herbal remedies. J Hepatol 1997; 26(Suppl 1): 47-51.
22. Wang HX, Liu M, Weng SY, et al. Immune mechanisms of Concanavalin A model of autoimmune hepatitis. World J Gastroenterol 2012; 18: 119-25.
23. Qazi MR, Hassan M, Nelson BD, Depierre JW, Abedi-Valugerdi M. Both sub-acute, moderate-dose and short-term, low-dose dietary exposure of mice to perfluorooctane sulfonate exacerbates concanavalin A-induced hepatitis. Toxicol Lett 2013; 217: 67-74.
24. Gorham JD, Lin JT, Sung JL, Rudner LA, French MA. Genetic regulation of autoimmune disease: BALB/c background TGF-beta 1-deficient mice develop necroinflammatory IFN-gamma-dependent hepatitis. J Immunol 2001; 166: 6413-22.
25. Lin JT, Kitzmiller TJ, Cates JM, Gorham JD. MHC-independent genetic regulation of liver damage in a mouse model of autoimmune hepatocellular injury. Lab Invest 2005; 85: 550-61.
26. Itoh S, Marutani K, Nishijima T, Matsuo S, Itabashi M. Liver injuries induced by herbal medicine, syo-saiko-to (xiao-chai-hu-tang). Dig Dis Sci 1995; 40: 1845-8.
27. Kamiyama T, Nouchi T, Kojima S, et al. Autoimmune hepatitis triggered by administration of an herbal medicine. Am J Gastroenterol 1997; 92: 703-4.
28. Wang JY, Chiu JH, Tsai TH, et al. Gene expression profiling predicts liver responses to a herbal remedy after partial hepatectomy in mice. Int J Mol Med 2005; 16: 221-31.
29. Wang JY, Chuang HN, Chiu JH, et al. Effects of Scutellaria baicalensis Georgi on macrophage-hepatocyte interaction through cytokines related to growth control of murine hepatocytes. Exp Biol Med (Maywood) 2006; 231: 444-55.
30. Lee CY, Hsu YC, Wang JY, Chen CC, Chiu JH. Chemopreventive effect of selenium and Chinese medicinal herbs on N-nitrosobis(2-oxopropyl)amine-induced hepatocellular carcinoma in Syrian hamsters. Liver Int 2008; 28: 841-55.
31. Teufel A, Galle PR, Kanzler S. Update on autoimmune hepatitis. World J Gastroenterol 2009; 15: 1035-41.
32. Vergani D, Longhi MS, Bogdanos DP, Ma Y, Mieli-Vergani G. Autoimmune hepatitis. Semin Immunopathol 2009; 31: 421-35.
33. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
34. Wang JY, Lee YT, Chang PF, Chau LY. Hemin promotes proliferation and differentiation of endothelial progenitor cells via activation of AKT and ERK. J Cell Physiol 2009; 219: 617-25.
35. Maddrey WC. Drug-induced hepatotoxicity: 2005. J Clin Gastroenterol 2005; 39 (4 Suppl 2): S83-9.
36. Czaja AJ. Autoantibody-negative autoimmune hepatitis. Dig Dis Sci 2012; 57: 610-24.
37. Lapierre P, Beland K, Djilali-Saiah I, Alvarez F. Type 2 autoimmune hepatitis murine model: the influence of genetic background in disease development. J Autoimmun 2006; 26: 82-9.
38. Vergani D, Mieli-Vergani G. Aetiopathogenesis of autoimmune hepatitis. World J Gastroenterol 2008; 14: 3306-12.
39. Donaldson PT. Genetics in autoimmune hepatitis. Semin Liver Dis 2002; 22: 353-64.
40. Sakaguchi K, Kitano M, Nishimura M, et al. Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis. Hepatogastroenterology 2004; 51: 1780-3.
41. Zou L, Harkey MR, Henderson GL. Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity. Life Sci 2002; 71: 1579-89.